RT @Pulmonary_Ther: Our number 3 most downloaded article last year was a post-hoc analysis looking at umeclidinium/vilanterol vs tiotropium…
RT @Pulmonary_Ther: Our number 3 most downloaded article last year was a post-hoc analysis looking at umeclidinium/vilanterol vs tiotropium…
RT @Pulmonary_Ther: Our number 3 most downloaded article last year was a post-hoc analysis looking at umeclidinium/vilanterol vs tiotropium…
RT @Pulmonary_Ther: Our number 3 most downloaded article last year was a post-hoc analysis looking at umeclidinium/vilanterol vs tiotropium…
Our number 3 most downloaded article last year was a post-hoc analysis looking at umeclidinium/vilanterol vs tiotropium/olodaterol in patients with #COPD: https://t.co/rblEqrDnYC https://t.co/BbhgfpSJGY
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @banavarrete: ¿Existen diferencias entre las combinaciones LABA/LAMA en la #EPOC cuando se utilizan como primera línea de tratamiento? E…
RT @banavarrete: ¿Existen diferencias entre las combinaciones LABA/LAMA en la #EPOC cuando se utilizan como primera línea de tratamiento? E…
RT @banavarrete: ¿Existen diferencias entre las combinaciones LABA/LAMA en la #EPOC cuando se utilizan como primera línea de tratamiento? E…
RT @banavarrete: ¿Existen diferencias entre las combinaciones LABA/LAMA en la #EPOC cuando se utilizan como primera línea de tratamiento? E…
¿Existen diferencias entre las combinaciones LABA/LAMA en la #EPOC cuando se utilizan como primera línea de tratamiento? Esta semana se ha publicado un trabajo que arroja luces a esta pregunta https://t.co/LdjesZbQmC
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @pulmonology101: Efficacy difference between UMEC/VI and TIO/OLO demonstrated in the ITT population is maintained in maintenance-naive p…
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
RT @pulmonology101: Efficacy difference between UMEC/VI and TIO/OLO demonstrated in the ITT population is maintained in maintenance-naive p…
RT @pulmonology101: Efficacy difference between UMEC/VI and TIO/OLO demonstrated in the ITT population is maintained in maintenance-naive p…
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
Efficacy difference between UMEC/VI and TIO/OLO demonstrated in the ITT population is maintained in maintenance-naive patients. Greater lung function with UMEC/VI versus TIO/OLO were accompanied by symptom improvements, as reflected in a lower need for res
RT @Pulmonary_Ther: Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve…
Summary of a new post hoc analysis investigating umeclidinium/vilanterol vs tiotropium/olodaterol in maintenance-naïve patients with moderate symptomatic #COPD. Read the complete #openaccess paper here: https://t.co/8yNdfaz6MJ https://t.co/UhG4vCtkN7